Walter Elliott
Nurse Practitioner · Neptune, NJNPI 1316409857
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,197 of the $12,715 with a category attached, or 72.3%. Merck accounts for 73.5% of it on its own, with 37 other manufacturers making up the rest. Reporting peaked in 2023 at $9,957 and has fallen 87.9% since, to $1,208 in 2025. Among nurse practitioner clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 146 payments — averaging $87.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$9K
- Incyte Corporation$467
- Daiichi Sankyo Inc.$416
- Amgen$287
- Astellas Pharma US Inc$259
- Sanofi-aventis U.S. LLC$204
- plus $2K from 32 others
What the payments were for
- Travel & lodging$9,19772%
- Food & beverage$3,27426%
- Education$2442%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 11 | $9,351 |
| Incyte Corporation | 5 | $467 |
| Daiichi Sankyo Inc. | 23 | $416 |
| Amgen | 16 | $287 |
| Astellas Pharma US Inc | 8 | $259 |
| Sanofi-aventis U.S. LLC | 7 | $204 |
| Novartis | 8 | $188 |
| E.r. Squibb & Sons, L.L.C. | 1 | $135 |
| AstraZeneca | 8 | $132 |
| Sobi, Inc | 1 | $124 |
| Taiho Oncology, Inc. | 8 | $121 |
| Geron Corporation | 1 | $115 |
| GSK | 1 | $108 |
| Bayer | 5 | $103 |
| Eisai Inc. | 6 | $87 |
| Johnson & Johnson | 3 | $78 |
| Regeneron Healthcare Solutions, Inc. | 3 | $46 |
| Blueprint Medicines Corporation | 3 | $43 |
| Foundation Medicine, Inc. | 3 | $41 |
| Bristol Myers Squibb | 2 | $41 |
| AbbVie | 2 | $37 |
| Melinta Therapeutics, LLC | 2 | $35 |
| Cumberland Pharmaceuticals, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Sanofi | 2 | $29 |
| Apellis Pharmaceuticals, Inc. | 1 | $20 |
| Adaptive Biotechnologies Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Pfizer | 1 | $17 |
| Deciphera Pharmaceuticals Inc. | 1 | $16 |
| ADC Therapeutics America, Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| EMD Serono, Inc. | 1 | $15 |
| Servier Pharmaceuticals LLC | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,715 in reported general payments places this provider in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 23 | $316 |
| Acyclovir | 19 | $174 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Neptune
- Stacey MustoNeptune$8K
- Joni PrenticeNeptune$7K
- Nancy BonnetMorristown$407K
- Vanessa CoppolaCloster$205K
- Olufunmilayo IloriUnion$133K
- Janice BeitzHaddon Heights$75K
- Adewale AdefowojuUnion$70K
- Sophia KimEnglewood$70K
- Elizabeth FletcherCamden$62K
- Lannae EwingLinwood$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.